Latest news
Adjuvia Therapeutics Raises $8 Million Series Seed To Advance ATI-105 Into Clinical Trials - Pulse 2.0Pulse 2.0 · Thu, 30 Jul 2026 02:32:37 GMTAdjuvia Therapeutics Closes $8 Million Series Seed Financing to Advance Novel Mitochondrial Disease Therapy into the Clinic - Business WireBusiness Wire · Wed, 29 Jul 2026 13:00:00 GMTCorner Health Announces $32.5 Million in Seed and Series A Financing | TytoCare Names Adam Pellegrini as CEO and Closes $25M+ Growth Round - healthcareittoday.comhealthcareittoday.com · Tue, 28 Jul 2026 13:03:24 GMT